Compounders Research Compare

Climb Bio, Inc.(CLYM)

Biotechnology · Wellesley Hills, MA

$11.05+0.11 (+1.01%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Climb Bio, Inc.

Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.

Wellesley Hills, MA

28 employees

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Aoife Brennan BCh MMSc

View full financials

Climb Bio (CLYM) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T12:51:02.994Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:51:02.994Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -0.83
Quote price: 11.05

FMP input reference: 979ff17a100a324a490b4ea8bab969f4c23ca35a684dd985742eca9c7cd70937

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

CLYM Earnings Yield Metrics

EARNINGS YIELD

N/A

CLYM Competitors' Earnings Yield

Climb Bio, Inc.

Current

Market Cap

$632.76M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Fulgent Genetics, Inc.

Market Cap

$637.59M

Earnings Yield

N/A

TTM Avg

25.29%

3Y Avg

18.23%

5Y Avg

18.23%

AngioDynamics, Inc.

Market Cap

$642.31M

Earnings Yield

N/A

TTM Avg

2.32%

3Y Avg

2.32%

5Y Avg

1.62%

Aura Biosciences, Inc.

Market Cap

$643.37M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aclaris Therapeutics, Inc.

Market Cap

$596.36M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

4D Molecular Therapeutics, Inc.

Market Cap

$675.41M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BlossomHill Therapeutics, Inc.

Market Cap

$579.88M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Annexon, Inc.

Market Cap

$688.14M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aquestive Therapeutics, Inc.

Market Cap

$573.38M

Earnings Yield

N/A

TTM Avg

0.20%

3Y Avg

0.20%

5Y Avg

0.20%

CorMedix Inc.

Market Cap

$569.56M

Earnings Yield

29.34%

TTM Avg

23.65%

3Y Avg

17.74%

5Y Avg

17.74%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Climb Bio, Inc. (CLYM)	$632.76M	N/A	N/A	N/A	N/A
Fulgent Genetics, Inc. (FLGT)vs ›	$637.59M	N/A	25.29%	18.23%	18.23%
AngioDynamics, Inc. (ANGO)vs ›	$642.31M	N/A	2.32%	2.32%	1.62%
Aura Biosciences, Inc. (AURA)vs ›	$643.37M	N/A	N/A	N/A	N/A
Aclaris Therapeutics, Inc. (ACRS)vs ›	$596.36M	N/A	N/A	N/A	N/A
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$675.41M	N/A	N/A	N/A	N/A
BlossomHill Therapeutics, Inc. (BLSM)vs ›	$579.88M	N/A	N/A	N/A	N/A
Annexon, Inc. (ANNX)vs ›	$688.14M	N/A	N/A	N/A	N/A
Aquestive Therapeutics, Inc. (AQST)vs ›	$573.38M	N/A	0.20%	0.20%	0.20%
CorMedix Inc. (CRMD)vs ›	$569.56M	29.34%	23.65%	17.74%	17.74%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics